[go: up one dir, main page]

WO1990015600A3 - Traitement pour maladie chronique inflammatoire des articulationspar des arylsulfonamides - Google Patents

Traitement pour maladie chronique inflammatoire des articulationspar des arylsulfonamides Download PDF

Info

Publication number
WO1990015600A3
WO1990015600A3 PCT/US1990/003391 US9003391W WO9015600A3 WO 1990015600 A3 WO1990015600 A3 WO 1990015600A3 US 9003391 W US9003391 W US 9003391W WO 9015600 A3 WO9015600 A3 WO 9015600A3
Authority
WO
WIPO (PCT)
Prior art keywords
arylsulfonamides
chronic inflammatory
joint disease
inflammatory joint
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1990/003391
Other languages
English (en)
Other versions
WO1990015600A2 (fr
Inventor
Joseph Clarence Nolan
Richard John Barrett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AH Robins Co Inc
Original Assignee
AH Robins Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AH Robins Co Inc filed Critical AH Robins Co Inc
Publication of WO1990015600A2 publication Critical patent/WO1990015600A2/fr
Anticipated expiration legal-status Critical
Publication of WO1990015600A3 publication Critical patent/WO1990015600A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Procédé de traitement d'affections inflammatoires chroniques des articulations par des arylsulfonamides de formule: Z-SO2NR1R2, dans laquelle R1 et R2 sont sélectionnés parmi hydrogène, alkyle inférieur, alcényle inférieur, cycloalkyle, phényle, alkylphényle inférieur, 2 ou 3-pyrrolidinyle, 2 ou 3-(N-alkylpyrrolidinyle inférieur), ou R1 et R2 combinés peuvent former des radicaux amino hétérocycliques de pyrrolidinyle ou de pipéridinyle, et Z est un groupe aryle sélectionné parmi tétrazole substitué ou non substitué, 1,3,4-thiadiazole, 1,2,4-triazole, benzothiazole, benzimidazole, imidazole, pyridyle, 4,6-diméthyl pyrimidine, benzène ou naphtalène. On montre également les effets anti-inflammatoires de l'acétazolamide, du méthazolamide, de l'éthoxzolamide et du dichlorphénamide en cas d'arthrite induite par des adjuvants.
PCT/US1990/003391 1989-06-19 1990-06-18 Traitement pour maladie chronique inflammatoire des articulationspar des arylsulfonamides Ceased WO1990015600A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/367,873 US4990523A (en) 1989-06-19 1989-06-19 Treatment of chronic inflammatory joint disease with arylsulfonamides
US367,873 1989-06-19

Publications (2)

Publication Number Publication Date
WO1990015600A2 WO1990015600A2 (fr) 1990-12-27
WO1990015600A3 true WO1990015600A3 (fr) 1992-08-06

Family

ID=23448986

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1990/003391 Ceased WO1990015600A2 (fr) 1989-06-19 1990-06-18 Traitement pour maladie chronique inflammatoire des articulationspar des arylsulfonamides

Country Status (3)

Country Link
US (1) US4990523A (fr)
AU (1) AU5847490A (fr)
WO (1) WO1990015600A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707985A (en) * 1995-06-07 1998-01-13 Tanabe Seiyaku Co. Ltd. Naphthyl-, quinolyl- and isoquinolyl- sulfonamide derivatives as cell adhesion modulators
US20080152640A1 (en) * 2003-07-29 2008-06-26 Peter Prehm Means and Methods For Treating a Disease Which is Associated With an Excess Transport of Hyaluronan Across a Lipid Bilayer
TW200630337A (en) 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
US8247442B2 (en) 2006-03-29 2012-08-21 Purdue Pharma L.P. Benzenesulfonamide compounds and their use
US8791264B2 (en) 2006-04-13 2014-07-29 Purdue Pharma L.P. Benzenesulfonamide compounds and their use as blockers of calcium channels
WO2007118854A1 (fr) 2006-04-13 2007-10-25 Euro-Celtique S.A. Composés à base de benzènesulfonamide et leur utilisation
EP2086329B1 (fr) * 2006-10-26 2014-07-23 The Arizona Board of Regents on behalf of the University of Arizona Modulateurs d'aquaporine et procédés pour leur utilisation pour le traitement d'un oedème et d'un déséquilibre de fluides
NO2106260T3 (fr) * 2007-01-25 2018-05-05
US8399486B2 (en) 2007-04-09 2013-03-19 Purdue Pharma L.P. Benzenesulfonyl compounds and the use thereof
WO2009040659A2 (fr) 2007-09-28 2009-04-02 Purdue Pharma L.P. Composés benzènesulfonamides et leurs utilisations
AU2009228765B2 (en) 2008-03-24 2012-05-31 Novartis Ag Arylsulfonamide-based matrix metalloprotease inhibitors
EP2291349A2 (fr) 2008-04-14 2011-03-09 The Board of Regents of The University of Texas System Inhibiteurs de petites molécules du domaine d'homologie de la pleckstrine, et leurs méthodes d'utilisation
WO2014093988A2 (fr) 2012-12-14 2014-06-19 Phusis Therapeutics, Inc. Procédés et compositions pour l'inhibition de cnksr1
US10227356B2 (en) 2015-04-20 2019-03-12 Phusis Therapeutics, Inc. Compounds, compositions and methods for inhibiting CNKSR1

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2357246A1 (fr) * 1976-07-09 1978-02-03 Martinez Gerard Nouvelles compositions therapeutiques douees d'activite anti-inflammatoire, antalgique et anti-cellulitique
EP0201057A2 (fr) * 1985-05-02 1986-11-12 Research Corporation Technologies, Inc. Inhibiteurs d'anhydrase carbonique dirigés vers les os

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2357246A1 (fr) * 1976-07-09 1978-02-03 Martinez Gerard Nouvelles compositions therapeutiques douees d'activite anti-inflammatoire, antalgique et anti-cellulitique
EP0201057A2 (fr) * 1985-05-02 1986-11-12 Research Corporation Technologies, Inc. Inhibiteurs d'anhydrase carbonique dirigés vers les os

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Arch. Int. Pharmacodyn., vol. 174, no. 1, 1968, J.W. PERRINE et al.: "Use of the rotarod in determining grip strength in rats with adjuvant-induced arthritis", pages 192-198, see pages 192,193,195,197,196, table II *
Endocrinology, vol. 87, no. 6, 1970, L.C. WAITE et al.: "Inhibition of bone resorption by acetazolamide in the rat", pages 1129-1139, see the whole article *
J. PHARM. PHARMACOL., vol. 42, no. 8, August 1990, J.C. NOLAN et al.: "AHR-15010 a novel anti-arthritic agent", pages 533-537, see the whole article *
K.J. ISSELBACHER et al.: "Harrison's Principles of Internal Medicine", 9th edition, 1980, chapter 356: B.C. GILLILAND et al.: "Rheumatoid arthritis", McGraw-Hill Kogakusha, Ltd, Toyko, JP, pages 1872-1880, see pages 1873,1876 *
Pharmacology, vol. 31, no. 2, 1985, A.D. KENNY: "Role of carbonic anhydrase in bone: plasma acetazolamide concentrations associated with inhibition of bone loss", pages 97-107, see the whole article *

Also Published As

Publication number Publication date
US4990523A (en) 1991-02-05
AU5847490A (en) 1991-01-08
WO1990015600A2 (fr) 1990-12-27

Similar Documents

Publication Publication Date Title
WO1990015600A3 (fr) Traitement pour maladie chronique inflammatoire des articulationspar des arylsulfonamides
IL135537A0 (en) Substituted fused heterocyclic compounds
GB2228004B (en) Heterocyclic compounds
HU9202931D0 (en) Iso- and heterocyclic compounds anellated with imidazole ring as well as method for producing them
HUT41026A (en) Process for preparing 5-/6-imidazo/1,2-a/pyridyl/-pyridine derivatives
ATE108772T1 (de) Monopersulfate von amino-(poly)percarbonsäuren.
IE901162L (en) Antiallergy agents
ATE103270T1 (de) 1,3-dicarbonylverbindungen und ihre verwendung.
NO962717L (no) Diaryl-5,6-kondenserte, heterosykliske syrer som leukotrienantagonister
ZA894102B (en) Butenoic or propenoic acid derivative
ES2173466T3 (es) Derivados de anilinopeptido
EP0117345A3 (en) Aminopyrimidinones as histamine h2-antagonists
ZA822898B (en) Heterocyclic derivatives
EP0226447A3 (fr) Acétylènes hétéro-aromatiques contre l'hypertension
FI853948L (fi) Foerbaettrad komposition av antiinflammatoriska droger.
DE3788955D1 (de) Pyridinyl-Derivate von 2-Aminoacetamid.
DE68918651D1 (de) Verwendung von Imidazopyrazolderivaten als analgesische und antiinflammatorische Mittel.
AU3673089A (en) (1,3-imidazole, triazole pyrimidine or pyridine) amide N-substituted compounds with antifungal action
ATE137748T1 (de) Antimagengeschwür pyridyloxyderivate, verfahren zu deren herstellung und ihre verwendung
DE60037772D1 (de) Textilveredlungsmittel auf der Basis von Urethan-Alkylenoxidcopolymeren
TW257758B (en) Piperazine derivatives (1)
TH3061A (th) 2-(อัลคอกซิมิโนอัลคอกซีคาร์บอนิล)-เฟนนิลซัลโฟนิลซัลโฟนิลยูเรีย

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP KR

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP KR

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE

CFP Corrected version of a pamphlet front page

Free format text: ABSTRACT ADDED

NENP Non-entry into the national phase

Ref country code: CA